Since both augmented arterial stiffness and left ventricular (LV) diastolic dysfunction are associated with adverse cardiovascular prognosis, the aim of this study was to investigate the relationship between these two parameters in the early stages of essential hypertension.
Since both augmented arterial stiffness and left ventricular (LV) diastolic dysfunction are associated with adverse cardiovascular prognosis, the aim of this study was to investigate the relationship between these two parameters in the early stages of essential hypertension.
Towards this end, we studied 53 newly diagnosed patients with stage I-II essential hypertension (aged 51.5 years, office blood pressure (BP) ϭ 148/97 mmHg) and 29 age and sex-matched normotensive controls. LV diastolic function was assessed by measuring mitral annular velocities (peak early [Em] , and peak late diastolic velocity [Am] , Em/Am ratio) with pulsed Tissue Doppler Imaging (TDI). Measurements were performed on four separate sites (basal septal, lateral, anterior and inferior LV wall) and the average values were used. Aortic stiffness was evaluated by means of a computerized method (Complior SP), on the basis of pulse wave velocity (PWV) measurements.
Hypertensives compared to normotensives did not differ significantly regarding their metabolic status, while they had greater LV mass index (110 Ϯ 24 g/m 2 vs 95 Ϯ 20 g/m 2 , pϽ 0.01) and greater RWT (0.46 Ϯ 0.08 vs 0.4 Ϯ 0.04, pϽ0.001). Furthermore, hypertensives compared to normotensives exhibited greater PWV values (8.47 Ϯ 1.5 vs 7.48 Ϯ 1.2 cm/sec, pϽ0.003) and lower Em and Em/Am ratio values (8.4 Ϯ 1.4 vs 10 Ϯ 1.6 cm/sec and 0.82 Ϯ 0.09 vs 1.15 Ϯ 0.16 respectively, pϽ0.001 for both cases). In the total population, aortic PWV was positively correlated with age (rϭ0.353, pϽ0.001), office systolic BP (rϭ0.358, pϽ0.001), office diastolic BP(rϭ0.28, pϽ0.05) and RWT (rϭ0.424, pϽ0.001), while it was negatively associated with Em (rϭ-0.305, pϽ0.005) and Em/Am ratio (rϭ-0.437, pϽ0.001).
In conclusion, despite the absence of LV hypertrophy, increased aortic stiffness is associated with LV diastolic dysfunction in the early stages of essential hypertension, suggesting that there maybe a common pathophysiologic pathway linking these two entities.
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P-407 LEFT VENTRICULAR STRUCTURE AND FUNCTION AND DEVELOPMENT OF PREGNANCY-RELATED HYPERTENSIVE DISORDERS IN PREGNANT WOMEN WITH ALTERED UTERO-PLACENTAL FLOW
Altered utero-placental flow identifies women at higher risk of hypertensive complications. It has been observed that pregnant women who develop hypertensive disorders, and preeclampsia in particular, can present precocious hemodynamic modifications, long before clinical aspects become evident.
Aim of the present study was to evaluate if some echocardiographic aspects can precociously identify higher risk pregnant women.
Thirty-one consecutive pregnant women with altered utero-placental flow at 21-24 th week of gestation underwent complete colour-Dopplerechocardiography, and left ventricular (LV) structure and function were evaluated, with assessment of LV mass, relative wall thickness (RWT) and E/A rate. Clinical follow-up of pregnancy was therefore assessed to distinguish pregnant women in those with and without hypertensive complications. Among hypertensive complications we considered preeclampsia, chronic or gestational hypertension, and intrauterine growth retard.
The results are represented in the table: no significant differences between two groups as regard as evaluated parameters were observed.
In conclusion, none of the examined echocardiographic parameters seems to identify pregnant women at higher risk of developing hypertensive disorders, suggesting that structural and functional LV modifications observed in other clinical settings, for instance, preeclampsia, need hemodynamic overload typical of those conditions to become evident. 
Background:
We have shown that atrial natriuretic peptide (ANP) null mice (Nppa-/-) exhibit exaggerated left ventricular (LV) dysfunction, heart failure and reduced survival compared to wild type Nppaϩ/ϩ mice in response to transverse aortic constriction (TAC)-induced pressure overload stress. Further, we recently demonstrated that the selective mineralocorticoid receptor blocker eplerenone, administrated orally since weaning (3 wks of age), prevents LV dilation and cardiac failure induced by pressure overload in ANP deficient states, mainly due to an antifibrotic effect. This study tested the hypothesis that eplerenone treatment can reverse the exaggerated LV dilation and dysfunction after TAC in ANP null mice.
Methods: Male Nppa-/-and Nppaϩ/ϩ mice, 20 gms average weight, were subjected to TAC at 8-9 wks of age. A baseline echocardiogram was done 1 wk after TAC to evaluate LV size and function and subsequently they were fed eplerenone supplemented chow (ϳ200 mg/kg/d) for 3 wks. Vehicle-treated mice were controls. Echocardiograms were repeated at 1 and 3 wks after TAC. Blood was collected for aldosterone measurement at sacrifice.
Results: Eplerenone completely reversed the TAC-induced LV dilatation and systolic dysfunction observed in Nppa-/-mice, while they did differ in the Nppaϩ/ϩ groups. Serum aldosterone levels were significantly higher in the eplerenone treated mice compared to the vehicle groups, and lower in the Nppa-/-than Nppaϩ/ϩ mice.
Conclusions: Eplerenone completely reversed adverse cardiac dilation and systolic dysfunction related to systolic overload in ANP deficient states. We speculate that these observations may be relevant to the human 
